NBIX
Neurocrine Biosciences Inc
Price:  
124.39 
USD
Volume:  
775,176.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX Relative Valuation

-40.6%
Upside

As of 2025-06-16, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 73.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 124.39 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -40.6%.

The range of the Relative Valuation is 57.84 - 94.29 USD.

Range Selected
Trailing P/E multiples 18.7x - 23.4x 20.9x
Forward P/E multiples 16.6x - 23.8x 21.0x
Fair Price 57.84 - 94.29 73.92
Upside -53.5% - -24.2% -40.6%
124.39 USD
Stock Price
73.92 USD
Fair Price

NBIX Relative Valuation - Historical P/E Data

Date P/E
2025-06-11 40.19
2025-06-10 40.38
2025-06-09 40.69
2025-06-06 40.58
2025-06-05 40.33
2025-06-04 40.30
2025-06-03 40.46
2025-06-02 40.31
2025-05-30 39.81
2025-05-29 40.02
2025-05-28 39.82
2025-05-27 39.69
2025-05-23 38.90
2025-05-22 38.55
2025-05-21 39.02
2025-05-20 39.80
2025-05-19 39.75
2025-05-16 39.17
2025-05-15 38.92
2025-05-14 38.44
2025-05-13 37.82
2025-05-12 38.98
2025-05-09 37.45
2025-05-08 38.03
2025-05-07 39.36
2025-05-06 38.49
2025-05-05 35.52
2025-05-02 35.50
2025-05-01 34.50
2025-04-30 34.85
2025-04-29 34.71
2025-04-28 34.46
2025-04-25 34.54
2025-04-24 34.23
2025-04-23 33.41
2025-04-22 32.93
2025-04-21 32.58
2025-04-17 32.81
2025-04-16 32.40
2025-04-15 31.12
2025-04-14 30.71
2025-04-11 29.41
2025-04-10 29.36
2025-04-09 30.84
2025-04-08 28.33
2025-04-07 30.18
2025-04-04 30.96
2025-04-03 33.30
2025-04-02 35.05
2025-04-01 34.63